Company profile: Cryoniss
1.1 - Company Overview
Company description
- Provider of temperature-controlled biobanking and cold-chain logistics for life sciences, offering regulated storage of human biological samples at vapour phase liquid nitrogen, -80°C, -20°C, +4°C and ambient; cell banking and culture with next-day dispatch; bioreagents storage with cloud-based traceability; cell line QC testing via preferred suppliers; end-to-end sample transport; and access to samples for research.
Products and services
- Biobanking: Delivers regulated storage of human biological samples at vapor-phase liquid nitrogen (-196°C), -80°C, -20°C, +4°C, and ambient temperatures for reliable, controlled preservation across diverse research needs
- Logistics Support: Offers end-to-end cold-chain management for sample transportation, working with premium courier partners for coordinated logistics throughout shipping
- Bioreagents Storage: Supplies secure storage for biological reagents, manufactured bioreagent or diagnostic kits, with a cloud-based database for full traceability across inventories
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cryoniss
Telo Genomics
HQ: Canada
Website
- Description: Provider of telomere-based platforms for biopsies and related technologies in oncology and neurological diseases. Offerings include TeloView, which quantifies genomic instability by measuring the 3D structure and spatial organization of telomeres to assess disease aggressiveness and treatment response, and TeloView SMM, a molecular assay identifying high-risk Smouldering Multiple Myeloma patients for treatment intervention decisions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Telo Genomics company profile →
PanReac
HQ: Spain
Website
- Description: Provider of laboratory reagents and chemicals for industrial use, manufacturing and selling these products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PanReac company profile →
ArcticZymes Technologies
HQ: Norway
Website
- Description: Provider of enzymes and kits for medical research, developed and manufactured by a biotechnology company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ArcticZymes Technologies company profile →
Elegen
HQ: United States
Website
- Description: Provider of cell-free DNA synthesis solutions, including ENFINIA DNA producing long, complex linear DNA up to 7kb with 99.999% per-base accuracy, shipped in 6 to 8 business days; high-complexity DNA synthesis for challenging sequences like long repeats and GC-rich regions, with delivery as fast as 10 business days; and an Early Access Program for pre-commercial products, including sequences longer than 15,000 base pairs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Elegen company profile →
Union Biometrica
HQ: United States
Website
- Description: Provider of high-throughput large-particle (10-1500 micron) flow cytometry systems for analyzing, sorting and dispensing objects too large or fragile for traditional cytometers. Products include COPAS FP, BioSorter and VISION for sorting by size, length, optical density and multiple fluorescence channels. Systems handle cells, cell clusters and small model organisms. VAST BioImager enables automated high-throughput, high-content screening and cellular-resolution imaging of zebrafish larvae.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Union Biometrica company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cryoniss
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cryoniss
2.2 - Growth funds investing in similar companies to Cryoniss
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cryoniss
4.2 - Public trading comparable groups for Cryoniss
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →